Recent Company News

• 11:18 AM ET Dec 02, 2025
  

  Transcript Intelligence: EDAP TMS at Piper Sandler Healthcare Conference ($2.31, -0.02)

• 07:31 AM ET Nov 20, 2025
  

  EDAP receives FDA 510(k) clearance for latest evolution of Focal One Robotic HIFU ($2.23, 0.00)

• 12:38 PM ET Nov 18, 2025
  

  Transcript Intelligence: EDAP TMS at Jefferies Global Healthcare Conference ($2.06, -0.02)

• 07:46 AM ET Nov 06, 2025
  

  EDAP TMS reports Q3 EPS (€0.13) vs FactSet (€0.22) [3 est, (€0.26)-(0.19)] ($2.08, 0.00)

• 08:32 AM ET Oct 20, 2025
  

  EDAP TMS enters into a €36M multi-tranche credit facility with the EIB ($2.24, 0.00)

• 09:50 AM ET Oct 17, 2025
  

  Natural Killer Cell Therapies Lead $254B Immunotherapy Market Transformation

• 09:30 AM ET Sep 09, 2025
  

  Transcript Intelligence: EDAP TMS at H.C. Wainwright Global Investment Conference

• 07:07 AM ET Sep 08, 2025
  

  EDAP TMS Receives HIFU Reimbursement for Prostate Cancer in France ($2.52, 0.00)

• 07:08 AM ET Aug 28, 2025
  

  EDAP TMS reports Q2 EPS (€0.15) vs FactSet (€0.18) [1 est] ($1.58, 0.00)

• 07:06 AM ET Jul 01, 2025
  

  EDAP TMS announces transition to U.S. domestic filer status from foreign private issuer effective Jan 2026 ($1.65, 0.00)